Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Compared With Darunavir/Cobicistat Plus Tenofovir Alafenamide/Emtricitabine in Virologically Suppressed People Living With HIV at 24 and 48 Weeks of Follow-up

Clinical trial NCT07678268 · RECRUITING

Trial details

NCT number: NCT07678268
Sponsor: Instituto Mexicano del Seguro Social
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

HIV Infection Antiretroviral Therapy Lentivirus Infections

Start date: 2025-07-10
Primary completion: 2026-07-10
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.